Insmed Inc (INSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -144,961 | -68,524 | -192,649 | -127,265 | -82,086 |
| Depreciation Amortization | 9,585 | 4,089 | 3,677 | 2,259 | 1,515 |
| Accounts payable and accrued liabilities | 1,981 | -828 | 3,604 | -921 | 767 |
| Other Working Capital | -1,461 | -10,911 | 11,282 | -228 | -1,520 |
| Other Operating Activity | 12,531 | 8,761 | 14,469 | 14,759 | 8,166 |
| Operating Cash Flow | $-122,325 | $-67,413 | $-159,617 | $-111,396 | $-73,158 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,212 | -5,365 | -3,001 | -1,301 | -854 |
| Investing Cash Flow | $-8,212 | $-5,365 | $-3,001 | $-1,301 | $-854 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 450,000 | 450,000 | N/A | N/A | N/A |
| Debt Repayment | -55,000 | -55,000 | N/A | N/A | N/A |
| Common Stock Issued | 5,785 | 142 | 381,089 | 380,656 | 2,434 |
| Other Financing Activity | -17,070 | -16,976 | 0 | 0 | 0 |
| Financing Cash Flow | $383,715 | $378,166 | $381,089 | $380,656 | $2,434 |
| Exchange Rate Effect | -14 | 28 | 103 | 128 | 51 |
| Beginning Cash Position | 381,165 | 381,165 | 162,591 | 162,591 | 162,591 |
| End Cash Position | 634,329 | 686,581 | 381,165 | 430,678 | 91,064 |
| Net Cash Flow | $253,164 | $305,416 | $218,574 | $268,087 | $-71,527 |
| Free Cash Flow | |||||
| Operating Cash Flow | -122,325 | -67,413 | -159,617 | -111,396 | -73,158 |
| Capital Expenditure | -8,212 | -5,365 | -3,001 | -1,301 | -854 |
| Free Cash Flow | -130,537 | -72,778 | -162,618 | -112,697 | -74,012 |